BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 19169012)

  • 21. Proposed conditions for coverage directed toward dialysis facilities.
    Smetanka S
    Health Care Law Mon; 2005 Apr; ():3-11. PubMed ID: 15895752
    [No Abstract]   [Full Text] [Related]  

  • 22. Conditions for coverage fail to relieve administrative burden.
    Wish D
    Nephrol News Issues; 2005 Sep; 19(10):46-7, 51. PubMed ID: 16187648
    [No Abstract]   [Full Text] [Related]  

  • 23. Economic impact of case-mix adjusting the dialysis composite rate.
    Hirth RA; Roys EC; Wheeler JR; Messana JM; Turenne MN; Saran R; Pozniak AS; Wolfe RA
    J Am Soc Nephrol; 2005 May; 16(5):1172-6. PubMed ID: 15800122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The success of medicare's end-stage renal-disease program: the case for profits and the private marketplace.
    Lowrie EG; Hampers CL
    N Engl J Med; 1981 Aug; 305(8):434-8. PubMed ID: 7019710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The American health care system. The End Stage Renal Disease Program.
    Iglehart JK
    N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
    [No Abstract]   [Full Text] [Related]  

  • 26. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mission possible: vascular access-decreasing the use of catheters in the Texas hemodialysis community.
    Rosenblum AJ; Harbert G; Knotek B; Husni L
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S76-80. PubMed ID: 11053591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study of state surveying methods for ESRD facilities.
    Diamond L; Armistead N; Horansky C
    Nephrol News Issues; 1991 Jun; 5(6):43-4, 49-52. PubMed ID: 1961303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What Medical Directors Need to Know about Dialysis Facility Water Management.
    Kasparek T; Rodriguez OE
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1061-71. PubMed ID: 25979976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field?
    Gardner AV
    Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480
    [No Abstract]   [Full Text] [Related]  

  • 31. The dialysis facility of the future: the financial and social environment.
    Steinman TI
    Semin Nephrol; 1997 Jul; 17(4):298-305. PubMed ID: 9241715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney Failure? Dialysis is the only medical service without automatic inflation updates from Medicare. Some people are trying to change that.
    Zigmond J
    Mod Healthc; 2006 Nov; 36(44):6-7, 14-6, 1. PubMed ID: 17128943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection control requirements for dialysis facilities and clarification regarding guidance on parenteral medication vials.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Aug; 57(32):875-6. PubMed ID: 18701878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The QIP: will it improve dialysis care? An overview.
    Fishbane S; Miller I; Danko H; Masani N
    Nephrol News Issues; 2012 Jan; 26(1):20, 22-4, 26. PubMed ID: 22359961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to make the new Conditions for Coverage work in your dialysis clinic. Patient assessment.
    Deziel S; Bodin S
    Nephrol News Issues; 2008 Dec; 22(13):38, 40, 42. PubMed ID: 19149316
    [No Abstract]   [Full Text] [Related]  

  • 36. Medicare program: End-Stage Renal Disease program; revised network area designations--HCFA. Final rule.
    Fed Regist; 1987 Oct; 52(191):37018-25. PubMed ID: 10301901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Medicare Conditions of Participation for Hospitals.
    Liang FZ; Greenberg RB; Hogan GF
    Am J Hosp Pharm; 1987 May; 44(5):1119-22. PubMed ID: 3300302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the bundle on lab services.
    Burney M
    Nephrol News Issues; 2011 Jul; 25(8):14-5. PubMed ID: 21877618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comments on proposed conditions for coverage focus on patient care, training, facility upgrades.
    Leiby M
    Nephrol News Issues; 2005 Aug; 19(9):15-7. PubMed ID: 16173298
    [No Abstract]   [Full Text] [Related]  

  • 40. Should the medicare ESRD program pay for daily dialysis? An ethical analysis.
    Anantharaman P; Moss AH
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.